The Mindful Mood Balance (MMB) program, a digitally delivered version of mindfulness-based cognitive therapy, combined with usual depression care, produced greater improvements in decentering, mindfulness, and rumination than usual care alone among adults with residual depressive symptoms. Changes in these three processes each predicted a lower likelihood of depressive relapse. The findings indicate that the program's benefits operate through the same mechanisms as in-person mindfulness-based cognitive therapy and that these mechanisms can be engaged through digital delivery.
A review of 1,226 empirical studies on mindfulness-based interventions (MBIs) published between 2014 and 2025 found that most research remains in early stages of development, with 41% classified as Stage 1, 54% as Stage 2 or 3, 3% as Stage 4, and 2% as Stage 5 of the NIH Stage Model. Compared to a prior review, later-stage studies modestly increased, and attention to mechanisms and real-world implementation expanded substantially. However, effectiveness, dissemination, and implementation studies remain rare. The authors argue that translating efficacy into large-scale public health impact will require coordinated research across all stages and integrating basic, clinical, and implementation science.
Mindfulness Based Cognitive Therapy combines mindfulness meditation with cognitive theory to treat recurrent mood disorders. Despite strong evidence for its effectiveness, MBCT is not widely used in routine clinical or population health settings. Two key questions remain unresolved: how important is home practice of mindfulness skills for achieving benefits, and what role can digital platforms play in delivering mindfulness programs. Answering these questions could improve future research and practice, helping contemplative practices support self-care.